Welgene Biotech Co (ROCO:6661) Capital Expenditure : NT$-7.52 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Welgene Biotech Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Welgene Biotech Co's cash flow for capital expenditures for the three months ended in Sep. 2024 was NT$-2.4 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was NT$-7.52 Mil.

Welgene Biotech Co Capital Expenditure Historical Data

The historical data trend for Welgene Biotech Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welgene Biotech Co Capital Expenditure Chart

Welgene Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-8.64

-5.91

-4.38

-26.86

-27.73

Welgene Biotech Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Capital Expenditure	Get a 7-Day Free Trial															-15.90	-3.59	-1.46	-0.09	-2.38

Welgene Biotech Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-7.52 Mil.

Welgene Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Welgene Biotech Co Ltd (ROCO:6661) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Yuanqu Street, 12th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.welgene.com.tw

Welgene Biotech Co Ltd is engaged in providing clinical testing service. It service and products offerings include next-generation sequencing service, microarray service, OPS diagnostics products, and Biovesicle products. The company also offers clinical testing agents and instruments.

Welgene Biotech Co Headlines

No Headlines